Trial intelligence / Profile preview

Tacrolimus eye drops for herpetic corneal ulcer

IRCT2016102429871N2Phase 2Completed

Sponsor
Guilan University of Medical Sciences
Start
Jul 2016
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of tacrolimus in Herpetic Interstitial Keratitis (HIK), sponsored by Guilan University of Medical Sciences. Started Jul 2016; status: completed.

02

Drugs

tacrolimus
03

Conditions

Herpetic Interstitial Keratitis (HIK)

Beyond the preview

Go deeper on IRCT2016102429871N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016102429871N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call